Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 66030 [2016-23055]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
66030
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
of the meeting will be included in the
official record of the meeting.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP Web site: https://
www.cdc.gov/vaccines/acip/.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. §1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines. Further, under provisions of
the Affordable Care Act, at section 2713
of the Public Health Service Act,
immunization recommendations of the
ACIP that have been adopted by the
Director of the Centers for Disease
Control and Prevention and appear on
the CDC immunization schedules must
be covered by applicable health plans.
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccines; human
papillomavirus vaccines; influenza;
hepatitis vaccines; pertussis vaccines;
Respiratory Syncytial Virus (RSV); child
and adolescent immunization schedule;
adult immunization schedule; herpes
zoster vaccine; yellow fever vaccine;
pneumococcal vaccine and vaccine
supply. A recommendation vote is
scheduled for Hepatitis B vaccine,
pertussis vaccine, human
papillomavirus vaccines, meningococcal
vaccines, child and adolescent
immunization schedule, and adult
immunization schedule. A Vaccines for
Children (VFC) vote is scheduled for
human papillomavirus vaccines,
Hepatitis B vaccine and meningococcal
vaccines. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, Telephone:
(404) 639–8836; Email: ACIP@
CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23053 Filed 9–23–16; 8:45 am]
[FR Doc. 2016–23055 Filed 9–23–16; 8:45 am]
BILLING CODE 4160–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) GH16–007, Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Times and dates: 9:00 a.m.–2:00 p.m.,
EDT, Panel A, October 18, 2016
(Closed); 9:00 a.m.–2:00 p.m., EDT,
Panel B, October 19, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
GH16–007 Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Contact person for more information:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30329, Telephone: (404) 639–4796.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0457]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Page 66030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23055]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA)
GH16-007, Operations Research (Implementation Science) for
Strengthening Global Health Protection Implementation.
Times and dates: 9:00 a.m.-2:00 p.m., EDT, Panel A, October 18,
2016 (Closed); 9:00 a.m.-2:00 p.m., EDT, Panel B, October 19, 2016
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to GH16-007 Operations Research (Implementation Science) for
Strengthening Global Health Protection Implementation.
Contact person for more information: Hylan Shoob, Scientific Review
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30329, Telephone:
(404) 639-4796.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-23055 Filed 9-23-16; 8:45 am]
BILLING CODE 4163-18-P
